Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/163513
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Urpí Sardà, Mireia | - |
dc.contributor.author | Almanza Aguilera, Enrique | - |
dc.contributor.author | Llorach, Rafael | - |
dc.contributor.author | Vázquez Fresno, Rosa | - |
dc.contributor.author | Estruch Riba, Ramon | - |
dc.contributor.author | Corella Piquer, Dolores | - |
dc.contributor.author | Sorlí, José V. | - |
dc.contributor.author | Carmona Pontaque, Francesc | - |
dc.contributor.author | Sànchez, Àlex (Sànchez Pla) | - |
dc.contributor.author | Salas Salvadó, Jordi | - |
dc.contributor.author | Andrés Lacueva, Ma. Cristina | - |
dc.date.accessioned | 2020-06-02T06:25:35Z | - |
dc.date.available | 2020-06-02T06:25:35Z | - |
dc.date.issued | 2019-04-01 | - |
dc.identifier.issn | 1262-3636 | - |
dc.identifier.uri | https://hdl.handle.net/2445/163513 | - |
dc.description.abstract | Aim. - To characterize the urinary metabolomic fingerprint and multi-metabolite signature associated with type 2 diabetes (T2D), and to classify the population into metabotypes related to T2D. Methods. - A metabolomics analysis using the 1 H-NMR-based, non-targeted metabolomic approach was conducted to determine the urinary metabolomic fingerprint of T2D compared with non-T2D participants in the PREDIMED trial. The discriminant metabolite fingerprint was subjected to logistic regression analysis and ROC analyses to establish and to assess the multi-metabolite signature of T2D prevalence, respectively. Metabotypes associated with T2D were identified using the k-means algorithm. Results. - A total of 33 metabolites were significantly different (P < 0.05) between T2D and non-T2D participants. The multi-metabolite signature of T2D comprised high levels of methylsuccinate, alanine, dimethylglycine and guanidoacetate, and reduced levels of glutamine, methylguanidine, 3-hydroxymandelate and hippurate, and had a 96.4% AUC, which was higher than the metabolites on their own and glucose. Amino-acid and carbohydrate metabolism were the main metabolic alterations in T2D, and various metabotypes were identified in the studied population. Among T2D participants, those with a metabotype of higher levels of phenylalanine, phenylacetylglutamine, p-cresol and acetoacetate had significantly higher levels of plasma glucose. Conclusion. - The multi-metabolite signature of T2D highlights the altered metabolic fingerprint associated mainly with amino-acid, carbohydrate and microbiota metabolism. Metabotypes identified in this patient population could be related to higher risk of long-term cardiovascular events and therefore require further studies. Metabolomics is a useful tool for elucidating the metabolic complexity and interindividual variation in T2D towards the development of stratified precision nutrition and medicine | - |
dc.format.extent | 8 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier Masson SAS | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1016/j.diabet.2018.02.006 | - |
dc.relation.ispartof | Diabetes & Metabolism, 2019, vol. 45, num. 2, p. 167-174 | - |
dc.relation.uri | https://doi.org/10.1016/j.diabet.2018.02.006 | - |
dc.rights | (c) Elsevier Masson SAS, 2019 | - |
dc.source | Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) | - |
dc.subject.classification | Dietoteràpia | - |
dc.subject.classification | Metabolisme | - |
dc.subject.classification | Marcadors bioquímics | - |
dc.subject.classification | Diabetis no-insulinodependent | - |
dc.subject.classification | Medicina preventiva | - |
dc.subject.classification | Metabolòmica | - |
dc.subject.classification | Factors de risc en les malalties | - |
dc.subject.other | Diet therapy | - |
dc.subject.other | Metabolism | - |
dc.subject.other | Biochemical markers | - |
dc.subject.other | Non-insulin-dependent diabetes | - |
dc.subject.other | Preventive medicine | - |
dc.subject.other | Metabolomics | - |
dc.subject.other | Risk factors in diseases | - |
dc.title | Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 676649 | - |
dc.date.updated | 2020-06-02T06:25:35Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Genètica, Microbiologia i Estadística) Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
676649.pdf | 1.42 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.